Source: Fox News
Summary
The Food and Drug Administration (FDA) has approved the use of bemotrizinol, a new sunscreen ingredient, in the US. This is the first new sunscreen ingredient approved in over 25 years. Bemotrizinol has been used in Europe and other parts of the world and will be available in the US as Parsol Shield, manufactured by DSM Nutritional Products. The FDA has recognized bemotrizinol as safe and effective for adults and children 6 months and older.
Our Reading
The advice sounds familiar.
The FDA’s approval of bemotrizinol marks a new phase in sunscreen regulation. The agency has been criticized for moving slowly in this area, leaving Americans with fewer options than consumers abroad. The approval of bemotrizinol is seen as a step towards modernizing the regulation of sunscreen and other over-the-counter drug products. As the FDA continues to regulate sunscreen products, it encourages the public to use multiple protective measures, including broad-spectrum sunscreens SPF 15 or higher. The FDA’s guidance on sunscreen use has been consistent, but the introduction of new ingredients like bemotrizinol may lead to changes in recommendations.
Regulatory updates often follow a familiar pattern: a new ingredient is approved, and then guidelines are adjusted to reflect its use.
Author: Evan Null
